Show
Sort by
-
- Journal Article
- A1
- open access
Efficacy of the NS1-truncated live attenuated influenza virus vaccine for swine against infection with viruses of major North American and European H3N2 lineages
-
- Journal Article
- A1
- open access
Characterization of the cell-mediated immune response to Takeda’s live-attenuated tetravalent dengue vaccine in adolescents participating in a phase 2 randomized controlled trial conducted in a dengue-endemic setting
-
Understanding the public health value and defining preferred product characteristics for therapeutic human papillomavirus (HPV) vaccines : World Health Organization consultations, October 2021—March 2022
-
- Journal Article
- A1
- open access
Vaccine-associated enhanced disease : case definition and guidelines for data collection, analysis, and presentation of immunization safety data
-
- Journal Article
- A1
- open access
Vaccine effectiveness against infection and onwards transmission of COVID-19 : analysis of Belgian contact tracing data, January-June 2021
-
Proof-of-concept of a low-dose unmodified mRNA-based rabies vaccine formulated with lipid nanoparticles in human volunteers : a phase 1 trial
-
Immunogenicity and safety of a nine-valent human papillomavirus vaccine in women 27-45 years of age compared to women 16-26 years of age : an open-label phase 3 study
-
- Journal Article
- A1
- open access
A new fully liquid presentation of MenACWY-CRM conjugate vaccine : results from a multicentre, randomised, controlled, observer-blind study
-
New insights about vaccine effectiveness : Impact of attenuated PRRS-strain vaccination on heterologous strain transmission
-
- Journal Article
- A1
- open access
Persistence of vaccine-elicited immune response up to 14 years post-HIV gp120-NefTat/AS01(B) vaccination
-
- Journal Article
- A1
- open access
Role of antigen specific T and B cells in systemic and mucosal immune responses in ETEC and Shigella infections, and their potential to serve as correlates of protection in vaccine development
-
SapM mutation to improve the BCG vaccine : genomic, transcriptomic and preclinical safety characterization
-
Follow-up of serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae in child carriage after a PCV13-to-PCV10 vaccine switch in Belgium
-
- Journal Article
- A1
- open access
How genomics can be used to understand host susceptibility to enteric infection, aiding in the development of vaccines and immunotherapeutic interventions
-
- Journal Article
- A1
- open access
Human papillomavirus vaccination coverage in Luxembourg : implications of lowering and restricting target age groups
-
- Journal Article
- A1
- open access
Nasopharyngeal S. pneumoniae carriage and density in Belgian infants after 9 years of pneumococcal conjugate vaccine programme
-
New recommendations to prevent pain during immunizations : WHO position paper - September 2015
-
- Journal Article
- A1
- open access
Phase I, randomized, observer-blind, placebo-controlled studies to evaluate the safety, reactogenicity and immunogenicity of an investigational non-typeable Haemophilus influenzae (NTHi) protein vaccine in adults
-
A randomized, observer-blind phase Ib study to identify formulations and vaccine schedules of a trivalent Group B Streptococcus vaccine for use in non-pregnant and pregnant women
-
Reducing pain at the time of vaccination : WHO position paper, September 2015 : recommendations